Effects of the novel non-peptidyl low molecular weight radical scavenger IAC in different models of inflammation: a new perspective in anti- inflammatory therapy

Autor: Lorenzo Corsi
Rok vydání: 2010
Předmět:
Parkinson's disease
neurological disorders
L-arginine
bis (1-hydroxy-2
RNS
Pharmacology
guanosine triphosphate (GTP)
medicine.disease_cause
Biochemistry
Lipid peroxidation
chemistry.chemical_compound
Mice
Neuroprotective Properties
Piperidines
sclerosis
hydrophylic-ity/lipophylicity
Drug Discovery
neurodegenerative diseases
electron paramagnetic reso-nance (EPR)
FREE RADICALS
biology
intrinsic property
nitric oxide synthase
Chemistry
c-Jun N-terminal kinase (JNK)
protein kinase C (PKC)
IAC
maladaptive re-sponse
Anti-Inflammatory Agents
Non-Steroidal

ROS
Free Radical Scavengers
Alzheimer's disease
superoxide dismutase
nitrosative stress
Neuroprotection
cyclooxygenase
myeloperoxidase
Molecular Medicine
PGE2
superoxide
metalloproteinase
medicine.symptom
leukocyte
gastrointesti-nal (GI)
excitotoxicity
kappa B kinase (IKK-b)
Free Radicals
medicine.drug_class
Inflammatory bowel dis-eases (IBD)
6-tetramethyl-4-piperidinyl)-decandioate
Radical Scavenger
Inflammation
Lipid Peroxidation
2
6
re-active oxygen
nitrogen species
nitric oxide (NO)
non steroidal anti-inflammatory drugs (NSAIDs)
prostaglandins (PGs)
dysregulated
peroxyl
peroxynitrite radicals
oxidative stress status
xanthine oxidase
mitogen-activated protein kinase (p38-MAPK)
monocyte chemo-attractant protein-1 (MCP-1)
vascular cell adhesion molecule-1 (VCAM-1)
guanosine diphosphate (GDP)
deoxyribo-nucleic acid (DNA)
L-citrulline
indomethacin
gastric ulcers
pancreatic islets
reactive oxygen species (ROS)
bilateral common carotid artery occlusion (BCCO)
Anti-inflammatory
Nitric oxide
Superoxide dismutase
medicine
Animals
Humans
Organic Chemistry
Rats
biology.protein
Cyclooxygenase
Oxidative stress
Zdroj: Current medicinal chemistry. 17(32)
ISSN: 1875-533X
Popis: The bis (1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl)-decandioate called IAC, is a new non-peptidyl low molecular weight radical scavenger able to give a fast reaction with the majority of radical species involved in the oxidative stress. This intrinsic property might be of particular interest in all the processes where it presents an over production of reactive oxygen/nitrogen species (ROS/RNS) such as inflammation. Indeed, it is well known that systemic inflammatory response is associated with the production of ROS, nitric oxide (NO), which in turn deplete the endogenous GSH, mediating cytotoxicity. It has been shown that IAC through its antioxidant activity, exerted a protective effect in vitro in islets isolated from type-2 diabetic patients, and in vivo in a non-obese diabetic mouse model and in DNBS-induced colitis in rats. The ability of IAC to protect brain from ischemia, suggests a possible use of the compound in broad range of inflammatory-related diseases. It is well known that the use of non steroidal anti-inflammatory drugs (NSAIDs) is associated with a broad spectrum of untoward side-effects such as gastrointestinal ulceration. The major pathogenetic element in the development of these effects is the depletion of prostaglandins (PGs) through inhibition of cyclooxygenase. The evidence that IAC protects gastric mucosa in an animal model of indomethacin-induced ulcer, through local increase of PGE 2 levels and antioxidant activity, candidates this compound as a novel, promising, anti-inflammatory compound avoiding the major common untoward side-effects elicited by NSAID's.
Databáze: OpenAIRE